Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gillian Murphy

Showing results (151-160 of 208) with videos related to

Pageof 21
Sort By:
Cancer Research|June 7, 2011
Two novel determinants of etoposide resistance in small cell lung cancerMalcolm H Lawson, Natalie M Cummings, Doris M Rassl, et al.
The American Journal of Pathology|April 28, 2005
Matrix metalloproteinase-1 associates with intracellular organelles and confers resistance to lamin A/C degradation during apoptosisG Astrid Limb, Karl Matter, Gillian Murphy, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 19, 2011
Cross-domain inhibition of TACE ectodomainChristopher J Tape, Sofie H Willems, Sarah L Dombernowsky, et al.
Clinical Chemistry|July 27, 2002
Measurement of the noncomplexed free fraction of tissue inhibitor of metalloproteinases 1 in plasma by immunoassayMads N Holten-Andersen, Ib Jarle Christensen, Hans Jørgen Nielsen, et al.
The Journal of Biological Chemistry|August 20, 2016
The MET/Vascular Endothelial Growth Factor Receptor (VEGFR)-targeted Tyrosine Kinase Inhibitor Also Attenuates FMS-dependent Osteoclast Differentiation and Bone Destruction Induced by Prostate CancerKenta Watanabe, Michiko Hirata, Tsukasa Tominari, et al.
The Biochemical Journal|March 13, 2003
Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP)Joanna R Worley, Philip B Thompkins, Meng H Lee, et al.
Dalton Transactions (Cambridge, England : 2003)|December 21, 2005
Structural systematics of the [Cu(chelate)3][Y]2 series. An interesting crystallographic structural insight involving vibronic coupling and the Jahn-Teller effect (JTE). The syntheses and low temperature crystal structures of tris(2,2'bipyridyl)copper(II) tetraphenylborate and tris(2,2'bipyridyl)zinc(II) tetraphenylborateBrian Murphy, Moza Aljabri, Aaleya Mohamed Ahmed, et al.
Biochemical Society Symposium|November 1, 2003
Role of TIMPs (tissue inhibitors of metalloproteinases) in pericellular proteolysis: the specificity is in the detailGillian Murphy, Vera Knäuper, Meng-Huee Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 2014
Altered microRNA expression after infection with human cytomegalovirus leads to TIMP3 downregulation and increased shedding of metalloprotease substrates, including MICAGloria Esteso, Elisa Luzón, Elisabeth Sarmiento, et al.
Disease Markers|January 25, 2005
The matrix metalloproteinase-3 (MMP-3) 5A/6A promoter polymorphism is not associated with ischaemic heart disease: analysis employing a family based approachPaul G McGlinchey, Mark S Spence, Chris C Patterson, et al.
Pageof 21

Showing results (151-160 of 208) with videos related to

Sort By:
Pageof 21
Cancer Research|June 7, 2011
Two novel determinants of etoposide resistance in small cell lung cancerMalcolm H Lawson, Natalie M Cummings, Doris M Rassl, et al.
The American Journal of Pathology|April 28, 2005
Matrix metalloproteinase-1 associates with intracellular organelles and confers resistance to lamin A/C degradation during apoptosisG Astrid Limb, Karl Matter, Gillian Murphy, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 19, 2011
Cross-domain inhibition of TACE ectodomainChristopher J Tape, Sofie H Willems, Sarah L Dombernowsky, et al.
Clinical Chemistry|July 27, 2002
Measurement of the noncomplexed free fraction of tissue inhibitor of metalloproteinases 1 in plasma by immunoassayMads N Holten-Andersen, Ib Jarle Christensen, Hans Jørgen Nielsen, et al.
The Journal of Biological Chemistry|August 20, 2016
The MET/Vascular Endothelial Growth Factor Receptor (VEGFR)-targeted Tyrosine Kinase Inhibitor Also Attenuates FMS-dependent Osteoclast Differentiation and Bone Destruction Induced by Prostate CancerKenta Watanabe, Michiko Hirata, Tsukasa Tominari, et al.
The Biochemical Journal|March 13, 2003
Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP)Joanna R Worley, Philip B Thompkins, Meng H Lee, et al.
Dalton Transactions (Cambridge, England : 2003)|December 21, 2005
Structural systematics of the [Cu(chelate)3][Y]2 series. An interesting crystallographic structural insight involving vibronic coupling and the Jahn-Teller effect (JTE). The syntheses and low temperature crystal structures of tris(2,2'bipyridyl)copper(II) tetraphenylborate and tris(2,2'bipyridyl)zinc(II) tetraphenylborateBrian Murphy, Moza Aljabri, Aaleya Mohamed Ahmed, et al.
Biochemical Society Symposium|November 1, 2003
Role of TIMPs (tissue inhibitors of metalloproteinases) in pericellular proteolysis: the specificity is in the detailGillian Murphy, Vera Knäuper, Meng-Huee Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 2014
Altered microRNA expression after infection with human cytomegalovirus leads to TIMP3 downregulation and increased shedding of metalloprotease substrates, including MICAGloria Esteso, Elisa Luzón, Elisabeth Sarmiento, et al.
Disease Markers|January 25, 2005
The matrix metalloproteinase-3 (MMP-3) 5A/6A promoter polymorphism is not associated with ischaemic heart disease: analysis employing a family based approachPaul G McGlinchey, Mark S Spence, Chris C Patterson, et al.
Pageof 21